Alchemite is an AI-powered R&D platform that replaces trial-and-error with fast, data-driven discovery. It learns from small, messy, or incomplete datasets to predict outcomes and recommend high-performing formulations, materials, or process conditions.
By uncovering hidden relationships in experimental data, Alchemite helps teams design better experiments, reduce testing, and reach optimal solutions faster. It can fill data gaps, model complex systems, and guide decision-making across formulation, materials, and product development.
Already proven in industrial R&D, Alchemite has helped organizations cut experimental workload, accelerate timelines, and improve innovation success rates.
Deploying Alchemite involves integrating existing data, building predictive models, and embedding AI into everyday R&D workflows—unlocking faster, smarter, and more efficient innovation.
Intellegens provides advanced machine learning software designed to accelerate research and development across sectors such as chemicals, materials, life sciences, and manufacturing. The company's core product, the Alchemite™ Suite, utilizes a unique machine learning algorithm that is specifically engineered to train models from sparse, noisy, or incomplete experimental and process data. Unlike standard approaches that may struggle with limited datasets, Alchemite™ allows R&D teams to extract deep insights, validate data, and optimize complex products and processes without requiring extensive coding or advanced statistical expertise. The software is delivered as a suite of interoperable apps and can also be embedded as a computational engine within third-party platforms to augment existing R&D workflows.
By enabling organizations to predict outcomes and optimize formulations, the Alchemite™ technology helps customers reduce their experimental workloads by 50-80%, leading to faster innovation cycles, lower costs, and shortened time-to-market. Spun out from the University of Cambridge, the company collaborates closely with industry partners and academic institutions to apply its AI tools to critical challenges, ranging from drug discovery and additive manufacturing to the development of new alloys and sustainable materials. Intellegens supports these implementations through specialized scientific services, helping clients integrate machine learning as a standard productivity tool to improve efficiency and decision-making in highly regulated and research-intensive environments.